Seminars in Thrombosis and Hemostasis

Issue S 1 · Volume 29 · 2003 DOI: 10.1055/s-002-2987 Discussion and Debate on Thromboembolism Editor in Chief Eberhard F. Mammen M.D., Guest Editors Ajay K. Kakkar MBBS Ph.D. Sylvia Haas M.D. Mark Levine M.D.

PREFACE

001

Kakkar, Ajay K.; Haas, Sylvia; Levine, Mark: Venous Thromboembolism and Its Treatment in High-Risk Groups

Full Text
HTML
PDF (32 kb)

003

Prandoni, Paolo; Piccioli, Andrea; Pagnan, Antonio: Recurrent Thromboembolism in Cancer Patients: Incidence and Risk Factors

Full Text
HTML
PDF (86 kb)

009

Levine, Mark: Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients

Full Text
HTML
PDF (46 kb)

013

Kakkar, Ajay K.: Low-Molecular-Weight Heparins: Beyond Thrombosis in the Management of the Cancer Patient

Full Text
HTML
PDF (48 kb)

017

Haas, Sylvia: Venous Thromboembolism in Medical Patients-The Scope of the Problem

Full Text
HTML
PDF (99 kb)

023

Goldhaber, Samuel Z.: DVT Prevention: What Is Happening in the “Real World”?

Full Text
HTML
PDF (182 kb)

DEBATE ARTICLE

033

Schulman, Sam: Why Is Factor Xa Not a Better Target Than Factor IIa for Therapeutic Inhibition of Coagulation?

Full Text
HTML
PDF (80 kb)

037

Büller, Harry R.: Factor Xa Is a Superior Target to Factor IIa for Antithrombotic Therapies

Full Text
HTML
PDF (33 kb)